跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,904 条关于
“Dompé Pharmaceuticals”
全部
8,904
临床试验
526
药物
1,733
机构
2,045
资讯
4,600
去年
Palvella Therapeutics Appoints Rare Disease Commercial Expert Ashley Kline as Chief Commercial Officer
11个月前
Dompé Receives FDA Priority Voucher for Intranasal NGF Therapy Targeting NAION Vision Loss
9个月前
Dompé Initiates Phase 3 Trial of Dual-Mechanism Isocyclosporin for Atopic Keratoconjunctivitis
5个月前
Dompé Initiates Phase 2 Trial of Intranasal NGF for Spastic Cerebral Palsy in Italy
8年前
NICE Rejects Cenegermin for Rare Eye Disease, Citing Cost Concerns
去年
HanAll, Daewoong, and NurrOn Announce Positive Phase 1 Results for Parkinson's Disease Therapy HL192 (ATH-399A)
去年
Bora Pharmaceuticals Acquires Pyros Pharmaceuticals, Expanding Rare Disease Portfolio
去年
MIRA Pharmaceuticals to Acquire SKNY Pharmaceuticals, Expanding into $200 Billion Weight Loss and Smoking Cessation Markets
去年
ARIAD Pharmaceuticals Accelerates Ponatinib to Market
去年
OnKure Therapeutics Advances Mutant-Specific PI3Kα Inhibitor OKI-219 Following Merger
第 1 页,共 460 页
上一页
下一页